Completed PHASE4 INTERVENTIONAL 2-arm NCT05930171

Combined Lumbar Erector Spinae Plane Block and Pericapsular Nerve Group Block in Patients Undergoing Hip Surgeries

Analgesic Efficacy of Combined Lumbar Erector Spinae Plane Block and Pericapsular Nerve Group Block in Patients Undergoing Hip Surgeries

Sponsor: Menoufia University

Conditions Lumbar Erector Spinae Plane Block Pericapsular Nerve Group Block (PENG Block)

Interventions Postoperative conventional analgesia in form of Acetaminophen Ultrasound guided L-ESPB and PENG block using Bupivacaine

Updated 4 times since 2023 Last updated: Dec 27, 2023 Started: Feb 1, 2023 Primary completion: Aug 1, 2023 Completion: Dec 1, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05930171, this PHASE4 trial focuses on Lumbar Erector Spinae Plane Block and Pericapsular Nerve Group Block (PENG Block) and remains completed. Sponsored by Menoufia University, it has been updated 4 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2024 — Jul 2024 [monthly]

Completed PHASE4

Status: Active Not Recruiting → Completed
Aug 2023 — Jan 2024 [monthly]

Active Not Recruiting PHASE4

First recorded

Feb 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Menoufia University

Data source: Menoufia University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Menoufia, Egypt